Race differences in adherence to headache treatment appointments in persons with headache disorders

Journal of the National Medical Association

Volumn 100, Issue 2, 2008, Pages 247-255

  Heckman, Bernadette Davantes ^a   Holroyd, Kenneth A ^a   O'Donnell, Francis J ^b   Tietjen, Gretchen ^c   Utley, Christine ^c   Stillman, Mark ^d   Ellis, Gary ^a  

^a OHIO UNIVERSITY   (United States)

^b OrthoNeuro   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

African Americans; Barriers; Head; Health disparities; Socioeconomic status

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEADACHE; HEALTH CARE MANAGEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MORBIDITY; PRIORITY JOURNAL; RACE DIFFERENCE; SCREENING; SOCIOECONOMICS; TREATMENT PLANNING;

EID: 39549108130     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)31213-X     Document Type: Article

References (38)

1. O'Flynn N, Ridsdale L. Headache in primary care: how important is diagnosis to management? Br J Gen Pract. 2002;52(480):569-573.
2. Schappert SM. National ambulatory medical care survey: 1989 summary. Vital Health Stat. 1998;3:1-80.
3. Scher AI, Stewart WF, Lipton RB. Migraine and headache: a meta-analytic approach. In: Crombie IK, eds. Epidemiology of Pain. Seattle, WA: IAS Press; 1999:159-170.
4. Dahlöf CGH, Solomon GD. The burden of migraine to the individual suffer: a review. Eur J Neurol. 1998;5(6):525-533.
5. Holroyd K, Stensland M, Lipchik G, et al. Psychosocial correlates and impact of chronic tension-type headaches. Headache. 2000;40:3-16.
6. Lipton R, Hamelsky SW, Kolodner KB, et al. Migraine, quality life and depression: a population-based case control study. Neurology. 2000;284:2599-2605.
7. Lipton RB, Stewart WF, Ryan RE, et al. Efficacy and safety of acetaminophen, aspirin and caffeine in alleviating migraine headache pain. Arch Neurol. 1998;55:210-217.
8. VonKorff M, Stewart WF, Simon DJ, et al. Migraine and reduced work performance: A population-based diary study. Neurology. 1998;50:1741-1745.
9. Gesztelyi G, Bereczki D. Disability is the major determinant of the severity of depressive symptoms in primary headaches but not in low back pain. Cephalalgia. 2005;25:598-604.
10. Solomon, GD, Skobieranda FG, Gragg LA. Quality of life and well-being of headache patients: Measurement by the Medical Outcomes Study instrument. J Headache Pain. 1993;33:351-358.
11. Stewart WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267:64-69.
12. Stewart WF, Lipton RB, Simon D. Work-related disability: results from the American Migraine Study. Cephalalgia. 1996;16(4):231-238.
13. Charles H, Good CB, Hanusa BH, et al. Racial differences in adherence to cardiac medications. J Natl Med Assoc. 2003;95:17-27.
14. Ganz DA, Glynn RJ, Mogun H, et al. J Gen Intern Med. 2000;5(11):776-781.
15. Izquierdo-Porrera P, Reiner F. Correlates of exercise adherence in an African American church community. Cultur Divers Ethnic Minor Psychol. 2002;8(4)389-394.
16. Karter AJ, Ferrara A, Darbinian JA, et al. Self-monitoring of blood glucose: Language and financial barriers in a managed care population with diabetes. Diabetes Care. 2000;23(4):477-483.
17. Laine C, Newschaffer CJ, Zhang D, et al. Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis. Obstet Gynecol. 2000;95(2):167-173.
18. Ronsaville DS, Hakim RB. Well childcare in the United States: racial differences in compliance with guidelines. Am J Public Health. 2000;90:1436-1443.
19. Bosworth HB, Dudley T, Olsen, MK, et al. Racial differences in blood pressure control: potential explanatory factors. Am J Med. 2006;119:64-70.
20. Valenstein M, Blow FC, Copeland L, et al. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophr Bull. 2004;30(2):255-264.
21. Weng FL, Israni AK, Joffe MM, et al. Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol. 2005;16(6):839-848.
22. Dunbar-Jacob J, Holmes JL, Sereika S, et al. Factors associated with attrition of African Americans during the recruitment phase of a clinical trial examining adherence among individuals with rheumatoid arthritis. Arthritis Rheum. 2004;51(3):422-428.
23. Heckman TG, Carlson B. A randomized clinical trial of two telephone-delivered mental health interventions for HIV-infected rural persons. AIDS Behav. 2007;11:5-14.
24. Nicholson RA, Rooney M, Vo K, et al. Migraine care among different ethnicities: do disparities exist? Headache. 2006;46(5):756-765.
25. Gibbs TS, Fleischer ABJ, Feldman SR, et al. Health care utilization in patients with migraine. Headache. 2003;43:330-335.
26. Emeads J, Findlay H, Tugwell P, et al. Impact of migraine and tension type headache on life-style, consulting behavior, and medication use: a Canadian population survey. Can J Neurol Sci. 1993;20:131-137.
27. Boes CJ, Capobianco DJ. Chronic migraine and medication-overuse headache through the ages. Cephalalgia. 2005;25:378-390.
28. Rains JC, Lipchik G, Penzien D. Behavioral facilitation of medical treatment for headache-part I: review of headache treatment compliance. Headache. 2006;46:1387-1394.
29. Andersen R. Revisiting the behavioral model and access to medical care: Does it matter? J Health Soc Behav. 1995;36:1-10.
30. Spitzer R, Williams J, Kroenke K. Validity and utility of the PRIME-MD Patient Health Questionnaire in assessment of 3,000 obstetric-gynecologic patients: The PRIME-MD patient health questionnaire obstetrics-gynecology study. Am J Obstet Gyn. 2000;183:759-769.
31. Martin NJ, Holroyd KA, Penzien DB. The headache-specific locus of control scale: adaptation to recurrent headaches. Headache. 1990;30:729-734.
32. Vandecreek, L. O'Donnell, F. Psychometric characteristics of the Headache-Specific Locus of Control scale. Headache. 1992;32(5):239-241.
33. French, DJ, Holroyd, KA, Pinell, C, et al. Perceived self-efficacy and headache-related disability. Headache. 2000;40(8):647-656.
34. Zimet GD, Dahlem NW, Zimet SG, et al. The multidimensional scale of perceived social support. J Pers Assess. 1988;52:30-41.
35. Williams CC, Collins AA. The social construction of disability in schizophrenia. Qual Health Res. 2002;12:297-309.
36. Sargent J, Solbach P, Coyne L, et al. Results of a controlled experimental outcome study of non-drug treatments for the control of migraine headaches. J Behav Med. 1986;9:291-313.
37. Hart JD. Failure to complete treatment for headache: a multiple regression analysis. J Consult Clin Psychol. 1982;50(5):781-792.
38. Farmer MM, Ferraro KF. Are racial disparities in health conditional on socioeconomic status? Soc Sci Med. 2005;60:191-204.